Vanguard Group’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.42M Buy
1,556,600
+71,527
+5% +$68.6K ﹤0.01% 3677
2025
Q3
$1.32M Sell
1,485,073
-2,939
-0.2% -$4.28K ﹤0.01% 3705
2025
Q2
$3.21M Buy
1,488,012
+226,349
+18% +$820K ﹤0.01% 3367
2025
Q1
$6.07M Hold
1,261,663
﹤0.01% 3099
2024
Q4
$8.13M Buy
1,261,663
+18,756
+2% +$91.3K ﹤0.01% 3059
2024
Q3
$4.98M Buy
1,242,907
+36,802
+3% +$152K ﹤0.01% 3272
2024
Q2
$3.87M Buy
1,206,105
+39,915
+3% +$135K ﹤0.01% 3359
2024
Q1
$3.81M Sell
1,166,190
-51,437
-4% -$187K ﹤0.01% 3397
2023
Q4
$6.1M Buy
1,217,627
+1,058,443
+665% +$2.82M ﹤0.01% 3200
2023
Q3
$177K Buy
+159,184
New +$135K ﹤0.01% 4275
2022
Q4
Sell
-211,526
Closed -$343K 4546
2022
Q3
$343K Sell
211,526
-39,157
-16% -$69.2K ﹤0.01% 4313
2022
Q2
$422K Hold
250,683
﹤0.01% 4329
2022
Q1
$955K Hold
250,683
﹤0.01% 4222
2021
Q4
$1.72M Sell
250,683
-281
-0.1% -$2.68K ﹤0.01% 4098
2021
Q3
$2.98M Buy
250,964
+701
+0.3% +$6.98K ﹤0.01% 3916
2021
Q2
$2.7M Sell
250,263
-15,506
-6% -$162K ﹤0.01% 3876
2021
Q1
$3.4M Buy
265,769
+219,319
+472% +$2.65M ﹤0.01% 3709
2020
Q4
$313K Buy
46,450
+25,594
+123% +$145K ﹤0.01% 4031
2020
Q3
$93K Hold
20,856
﹤0.01% 4023
2020
Q2
$77K Hold
20,856
﹤0.01% 4004
2020
Q1
$74K Buy
20,856
+17,300
+487% +$128K ﹤0.01% 3972
2019
Q4
$32K Sell
3,556
-3,417
-49% -$54.5K ﹤0.01% 4066
2019
Q3
$129K Buy
6,973
+139
+2% +$3.16K ﹤0.01% 4009
2019
Q2
$144K Buy
6,834
+22
+0.3% +$680 ﹤0.01% 4017
2019
Q1
$245K Buy
6,812
+319
+5% +$13.6K ﹤0.01% 3887
2018
Q4
$280K Sell
6,493
-2,089
-24% -$114K ﹤0.01% 3837
2018
Q3
$499K Sell
8,582
-66
-0.8% -$4.34K ﹤0.01% 3852
2018
Q2
$768K Buy
8,648
+382
+5% +$38.4K ﹤0.01% 3754
2018
Q1
$736K Buy
8,266
+3,133
+61% +$379K ﹤0.01% 3722
2017
Q4
$577K Buy
5,133
+2,447
+91% +$293K ﹤0.01% 3715
2017
Q3
$483K Buy
+2,686
New +$644K ﹤0.01% 3759

Other funds holding MYO

Vanguard Group's MYO Position: Q4 2025 in Review

Vanguard Group increased its Myomo (MYO) stake by 4.8% in Q4 2025, buying an estimated $68.6K and bringing the position to 1,556,600 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Vanguard Group first reported a position in MYO in Q3 2017 and has held it in 31 quarters since. The position peaked at $8.13M in Q4 2024. 76 funds tracked by Wall St. Rank hold MYO as of Q4 2025.

  • Vanguard Group held 1,556,600 shares of Myomo worth $1.42M as of Q4 2025.
  • Vanguard Group bought 71,527 Myomo shares in Q4 2025, an estimated $68.6K.
  • Myomo made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3677 holding.
  • Vanguard Group first reported a position in Myomo in Q3 2017 and has held it in 31 quarters since.
  • Vanguard Group's Myomo position peaked at $8.13M in Q4 2024.
  • 76 funds tracked by Wall St. Rank held Myomo as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.